M
M D Gokhale
Researcher at National Institute of Virology
Publications - 50
Citations - 1037
M D Gokhale is an academic researcher from National Institute of Virology. The author has contributed to research in topics: Chikungunya & Aedes aegypti. The author has an hindex of 16, co-authored 46 publications receiving 815 citations.
Papers
More filters
Journal ArticleDOI
Serratia odorifera a midgut inhabitant of Aedes aegypti mosquito enhances its susceptibility to dengue-2 virus.
Anjali D Apte-Deshpande,Mandar S. Paingankar,M D Gokhale,Dileep N. Deobagkar,Dileep N. Deobagkar +4 more
TL;DR: It is proposed that the enhancement in the DENV-2 susceptibility of Ae.
Journal Article
Serratia odorifera mediated enhancement in susceptibility of Aedes aegypti for chikungunya virus.
TL;DR: The results of this study indicated that the enhancement in the CHIKV susceptibility of Ae.
Journal ArticleDOI
Administration of E2 and NS1 siRNAs Inhibit Chikungunya Virus Replication In Vitro and Protects Mice Infected with the Virus
Deepti Parashar,Mandar S. Paingankar,Satyendra Kumar,M D Gokhale,A. B. Sudeep,Sapana B. Shinde,Vidya A. Arankalle +6 more
TL;DR: It is suggested that RNAi capable of inhibiting CHIKV growth might constitute a new therapeutic strategy for controlling Chikungunya virus infection and transmission.
Journal ArticleDOI
Venereal Transmission of Chikungunya Virus by Aedes aegypti Mosquitoes (Diptera: Culicidae)
M. S. Mavale,Deepti Parashar,A B Sudeep,M D Gokhale,Y. S. Ghodke,Geevarghese Geevarghese,Vidya A. Arankalle,Akhilesh C. Mishra +7 more
TL;DR: It is demonstrated that infected male mosquitoes are capable of infecting females during mating, and this finding has significance because it may help in transmission of the virus to females venereally to start a new infection cycle.
Journal ArticleDOI
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques.
Pragya D Yadav,Raches Ella,Sanjay Kumar,Dilip R. Patil,Sreelekshmy Mohandas,Anita M. Shete,Krishna Mohan Vadrevu,Gaurav Bhati,Gajanan N. Sapkal,Himanshu Kaushal,Savita Patil,Rajlaxmi Jain,Gururaj Rao Deshpande,Nivedita Gupta,Kshitij Agarwal,M D Gokhale,Basavaraj Mathapati,Siddhanath Metkari,Chandrashekhar Mote,Dimpal A Nyayanit,Deepak Y. Patil,B. S. Sai Prasad,Annasaheb Suryawanshi,Manoj Kadam,Abhimanyu Kumar,Sachin Daigude,Sanjay Gopale,Triparna Majumdar,Deepak Mali,Prasad Sarkale,Shreekant Baradkar,Pranita Gawande,Yash Joshi,Sidharam Fulari,Hitesh Dighe,Sharda Sharma,Rashmi Gunjikar,Abhinendra Kumar,Kaumudi Kalele,V.K. Srinivas,Raman R. Gangakhedkar,Krishna Murthy Ella,Priya Abraham,Samiran Panda,Balram Bhargava +44 more
TL;DR: In this article, the authors developed and assessed the protective efficacy and immunogenicity of an inactivated SARS-CoV-2 vaccine in rhesus macaques, and the vaccine candidate BBV152 has completed Phase I/II (NCT04471519) clinical trials in India and is presently in phase III.